Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in Moderately to Severely Active Ulcerative Colitis
View Full LandscapeTarget Indication
Moderately to Severely Active Ulcerative Colitis
Clinical Trial
NCT03221036Last updated: 1/13/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Fabry Disease
Type 2 Diabetes Mellitus
Primary Immunodeficiency Diseases (PID)
Primary Immunodeficiency Disease
Hypertension